$KITE Headlines S&P 500 ends higher for first-

$KITE Headlines

S&P 500 ends higher for first-ever close above 2,000 3:32 p.m. Aug. 26, 2014 - Victor Reklaitis
Google buys Zync; Mobileye rallies, Orbitz falls 2:34 p.m. Aug. 26, 2014 - Angela Johnson
Kite Pharma shares fly high on study results 4:47 p.m. Aug. 25, 2014 - Wallace Witkowski
Kite Pharma shares surge 49% on drug study result 3:50 p.m. Aug. 25, 2014 - Wallace Witkowski

Cellectis Is Late To The CAR-T Cell Race, But Could Finish First 4:21 p.m. Jan. 2, 2015 - Seeking Alpha
UPDATE: Credit Suisse Raises PT On Kite Pharma On Strong Outlook For CAR-T 6:58 a.m. Jan. 2, 2015 - benzinga.com
Health Care IPO Filings Moving Into A Busy New Year 3:04 p.m. Dec. 31, 2014 - Investors Business Daily
Kite Pharma Files IND for Non-Hodgkin Lymphoma Drug - Analyst Blog 5:20 p.m. Dec. 29, 2014 - Zacks.com
7 Best Performing IPOs of Record-Breaking 2014 - Analyst Blog 9:41 a.m. Dec. 29, 2014 - Zacks.com
Alibaba Helps Boost IPO Market To Top Year Since 2010 2:46 p.m. Dec. 24, 2014 - Investors Business Daily
Alibaba Tops The 5 Most Watched IPOs In Booming 2014 1:47 p.m. Dec. 24, 2014 - Investors Business Daily
Kite Pharma submits IND for blood cancer candidate 1:26 p.m. Dec. 22, 2014 - Seeking Alpha
Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market 6:14 a.m. Dec. 22, 2014 - TheStreet.com
Cramer's Mad Money - Look At Red Hat Go (12/19/14) 5:26 a.m. Dec. 21, 2014 - Seeking Alpha
Juno Therapeutics IPO Hot As Cancer Curers In Demand 5:32 p.m. Dec. 19, 2014 - Investors Business Daily
Juno Therapeutics IPO Caps Big Year In Biotech Deals 11:47 a.m. Dec. 19, 2014 - Investors Business Daily
Bellicum Leaps On Biotech IPO, Setting Stage For Juno 11:44 a.m. Dec. 18, 2014 - Investors Business Daily
Juno Therapeutics: Saving The Best Biotech IPO For Last In 2014 11:13 a.m. Dec. 17, 2014 - Seeking Alpha
Juno Therapeutics Ups IPO Price In Hot Biotech Field 1:46 p.m. Dec. 16, 2014 - Investors Business Daily
IPO Calendar: Year Wrapping Up With Juno, OnDeck IPOs 4:46 p.m. Dec. 15, 2014 - Investors Business Daily
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
Cramer's Mad Money - The Good Isis (12/10/14) 4:43 a.m. Dec. 11, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: The Good News-Bad News of Lower Oil Prices 8:41 p.m. Dec. 10, 2014 - TheStreet.com
Kite Pharma Breaks Out, Again 10:41 a.m. Dec. 10, 2014 - benzinga.com


Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 8:31 a.m. Dec. 30, 2014 - GlobeNewswire
Kite Pharma Submits Investigational New Drug Application for Phase 1/2 Trial of KTE-C19, Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, for the Treatment of Refractory Aggressive Non-Hodgkin Lymphoma 12:40 p.m. Dec. 22, 2014 - GlobeNewswire
Kite Pharma Added to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 16, 2014 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
Kite Pharma Announces Pricing of Follow-On Offering 9:01 p.m. Dec. 10, 2014 - GlobeNewswire
BioPharm Insight Releases Hematological Cancer Report in Advance of American Society of Hematology (ASH) Annual Meeting Next Month 2:19 p.m. Nov. 24, 2014 - BusinessWire - BZX
Kite Pharma Announces Presentations at the Upcoming 56th American Society of Hematology Annual Meeting 8:01 a.m. Nov. 18, 2014 - GlobeNewswire
Could This Emerging Drug Developer Really Be Worth A Billion Dollars In Five Years? 8:03 a.m. Nov. 17, 2014 - ACCESSWIRE
Kite Pharma Receives Positive Opinion for Orphan Drug Designation in the European Union for KTE-C19, Kite's Lead Investigational Cancer Immunotherapy 8:02 a.m. Nov. 17, 2014 - GlobeNewswire
Kite Pharma Reports Third Quarter 2014 Results 3:20 p.m. Nov. 14, 2014 - GlobeNewswire
Kite Pharma to Participate in Three Upcoming Investor Conferences in November 2014 8:05 a.m. Nov. 5, 2014 - GlobeNewswire
Kite Pharma Announces Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) Experience Positive Results After Receiving Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells 7:01 a.m. Oct. 13, 2014 - GlobeNewswire
Kite Pharma to Participate in Gene Therapy Panel at the BIO Investor Forum 5:31 p.m. Oct. 3, 2014 - GlobeNewswire
Kite Pharma to Present at the 21st Annual NewsMakers in the Biotech Industry Investment Conference on Friday, September 26 11:56 a.m. Sept. 16, 2014 - GlobeNewswire
Upcoming Conferences, Market Activity, Drug Approval, and Earnings Release - Research Reports on Mallinckrodt, Vertex Pharmaceuticals, Kite, Bristol-Myers Squibb and Arrowhead 7:40 a.m. Aug. 29, 2014 - PR Newswire - PRF
Kite Pharma Announces Patients With Aggressive Non-Hodgkin's Lymphoma Experience Positive Results After Receiving Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells at the National Cancer Institute (NCI) 3:31 p.m. Aug. 25, 2014 - GlobeNewswire
Kite Pharma Reports Second Quarter 2014 Results 4:41 p.m. Aug. 14, 2014 - GlobeNewswire
Kite Pharma Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 6:31 a.m. June 23, 2014 - GlobeNewswire
Kite Pharma, Inc. (NASDAQ: KITE) to Ring The NASDAQ Stock Market Closing Bell 9:01 a.m. June 20, 2014 - GlobeNewswire
Kite Pharma Announces Pricing of Initial Public Offering 5:00 a.m. June 20, 2014 - GlobeNewswire